Skip to main content

Euphorie (E4i): The first ecosystem for innovation dedicated to precision medicine and women’s health

30 November 2022, Institut du Cerveau, Auditorium
From 10 am to 1 pm. Access as from 9:30 am

The evolution of medicine towards precision medicine, but also health crises such as covid 19, make the
development and accessibility of vaccines, tests, or treatments in emergency situations crucial. This requires the healthcare world to adopt digital technologies, information sciences, and an emergency, collaborative and ecosystem-based way of working.

Precision medicine will revolutionize the entire field of health in the short term. It is imperative to disseminate this culture, to make the tools accessible and to promote the formation of agile and efficient ecosystems. Knowledge and skills must learn to work together, to collaborate and to rapidly produce concrete innovations for the benefit of patients.

Ziwig owes the realization of its first diagnostic test to this culture. Therefore, it is now creating Euphorie, the first ecosystem dedicated to innovation in the field of precision medicine and women’s health.

Euphorie creates the conditions for transformative innovation oriented towards the development of concrete and actionable solutions that changes the reality for patients, the practices of health professionals and those
of industry. These conditions require the global mobilization “from the molecule to society” of what constitutes an environment that is not only favorable, but that is concretely and actively committed to innovation.

 PROGRAM

Welcome and introduction: why an ecosystem for innovation 

  • Corinne Fortin, General Secretary of Brain Institut
  • Yahya El Mir, Founder and President of Ziwig

Therapeutics related to precision medicine

  • Pascal Pujol, President of the french society of predictive and personalized medicine.
  • Jeanne Conry (USA), FIGO President (International Federation of Obstetric gynecology)

Round table discussion

  •  Erika Saillant, Marketing and Strategy Director, GE France
  • Michelle Nisolle (BE), Director  of LUCERM (Liège Universitary Center of Endometriosis and Reproductive Medicine)
  • Amaury Martin, Deputy Director of the Institut Curie
  • Elodie Chapel, Elixir CEO
  • Priscilla Saracco, Patiente-expert of the Endomind association

A dynamic, international and opérational ecosystem

  • Franck Mouthon, President of France Biotech

Round table discussion

  • Denise Silber, Associate Director of the National Institute of E-Health
  • Olivier Goëau Brissonnière, President of the Federation of Medical Specialties
  • Julien Delpech, Founder of Invivox
  • Johanna Lerfel, General Delegate of French Healthcare Association
  • Stéphanie Combes, Managing Director of the Health Data Hub
  • Chahra Louafi, Director of the Autonomous Patient Fund, BPI – France
  • Vincent Meunier, Managing Director, Healthcare Investment Banking – Bryan, Garnier & Co.

Conclusion